Lindenane sesquiterpenoid dimers from Chloranthus japonicus inhibit HIV-1 and HCV replication

Fitoterapia

Volumn 115, Issue , 2016, Pages 64-68

  Yan, Huan ^a   Ba, Ming Yu ^b   Li, Xu Hong ^a   Guo, Jia Mei ^b   Qin, Xu Jie ^a   He, Li ^c   Zhang, Zhong Quan ^d   Guo, Ying ^b   Liu, Hai Yang ^a  

^a KUNMING INSTITUTE OF BOTANY   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c KUNMING MEDICAL UNIVERSITY   (China)

^d RESEARCH INSTITUTE OF FORESTRY   (China)

Author keywords

Anti HCV; Anti HIV 1; Chlorajaponilides F H; Chloranthus japonicus

Indexed keywords

CHLOJAPOLIDE G; CHLORAJAPONILIDE F; CHLORAJAPONILIDE G; CHLORAJAPONILIDE H; CHLORAMULTILIDE B; DIMER; DIMETHYL SULFOXIDE; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RIBAVIRIN; SARCANDROLIDE F; SARCANDROLIDE G; SESQUITERPENOID; SHIZUKAOL E; SHIZUKAOL G; SPICACHLORANTIN H; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; SESQUITERPENE;

ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; CHLORANTHUS JAPONICUS; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; EC50; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION; VIRUS STRAIN; WILD TYPE; ANGIOSPERM; CHEMISTRY; DRUG EFFECTS; HEK293 CELL LINE; HEPACIVIRUS; ISOLATION AND PURIFICATION; PHYSIOLOGY;

ANGIOSPERMS; ANTIVIRAL AGENTS; HEK293 CELLS; HEPACIVIRUS; HIV-1; HUMANS; MOLECULAR STRUCTURE; SESQUITERPENES; VIRUS REPLICATION;

EID: 84989954975     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2016.09.023     Document Type: Article

References (24)

1. [1] WHO, Progress Report 2011: Global HIV/AIDS Response. Available at: http://www.who.int/hiv/pub/progress_report2011/en/.
2. [2] Shepard, C.W., Finelli, L., Alter, M.J., Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5 (2005), 558–567.
3. [3] Lavanchy, D., The global burden of hepatitis C. Liver Int. 29:Suppl 1 (2009), 74–81.
4. [4] Cheng, J.J., Li, J.R., Huang, M.H., Ma, L.L., Wu, Z.Y., Jiang, C.C., Li, W.J., Li, Y.H., Han, Y.X., Li, H., Chen, J.H., Wang, Y.X., Song, D.Q., Peng, Z.G., Jiang, J.D., CD36 is a co-receptor for hepatitis C virus E1 protein attachment. Sci. Rep., 6, 2016, 21808.
5. [5] Kostova, I., Coumarins as inhibitors of HIV reverse transcriptase. Curr. HIV Res. 4 (2006), 347–363.
6. [6] Lee, K.H., Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach. J. Nat. Prod. 73 (2010), 500–516.
7. [7] Pan, L.L., Fang, P.L., Zhang, X.J., Ni, W., Li, L., Yang, L.M., Chen, C.X., Zheng, Y.T., Li, C.T., Liu, H.Y., Tigliane-type diterpenoid glycosides from Euphorbia fischeriana. J. Nat. Prod. 74 (2011), 1508–1512.
8. [8] Azzam, H.S., Goertz, C., Fritts, M., Jonas, W.B., Natural products and chronic hepatitis C virus. Liver Int. 27 (2007), 17–25.
9. [9] Calland, N., Dubuisson, J., Rouillé, Y., Séron, K., Hepatitis C virus and natural compounds: a new antiviral approach?. Viruses 4 (2012), 2197–2217.
10. [10] Fang, P.L., Cao, Y.L., Pan, L.L., Liu, S.C., Gong, N.B., Lü, Y., Chen, C.X., Zhong, H.M., Guo, Y., Liu, H.Y., Lindenane disesquiterpenoids with anti-HIV-1 activity from Chloranthus japonicus. J. Nat. Prod. 74 (2011), 1408–1413.
11. [11] Yang, Y., Cao, Y.L., Liu, H.Y., Yang, H., Guo, Y., Shizukaol F: a new structural type inhibitor of HIV-1 reverse transcriptase RNase H. Yao Xue Xue Bao 47 (2012), 1011–1016.
12. [12] College, J.N.M., Dictionary of Chinese Traditional Medicine. 1977, Shanghai Press of Science and Technology, Shanghai, 2169.
13. [13] Sagnelli, C., Martini, S., Pisaturo, M., Pasquale, G., Macera, M., Zampino, R., Coppola, N., Saqnelli, E., Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: diagnostic methods and clinical impact. World J. Hepatol. 7 (2015), 2510–2521.
14. [14] Liberto, M.C., Zicca, E., Pavia, G., Quirino, A., Marascio, N., Torti, C., Focà, A., Virological mechanisms in the coinfection between HIV and HCV. Mediat. Inflamm., 2015, 2015, 320532.
15. [15] Cao, Y.L., Li, S.X., Chen, H., Guo, Y., Establishment of pharmacological evaluation system for non-nucleoside reverse-transcriptase inhibitors resistant HIV-1. Yao Xue Xue Bao 44 (2009), 355–361.
16. [16] Wang, D., Lu, W., Li, F., Pharmacological intervention of HIV-1 maturation. Acta Pharm. Sin. B 5 (2015), 493–499.
17. [17] Miyamoto, M., Kato, T., Mizokami, M., Wakita, T., Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1 NK5. 1). Intervirology 49 (2006), 37–43.
18. [18] Guo, Y.Q., Zhao, J.J., Li, Z.Z., Tang, G.H., Zhao, Z.M., Yin, S., Natural nitric oxide (NO) inhibitors from Chloranthus japonicus. Bioorg. Med. Chem. Lett. 26 (2016), 3163–3166.
19. [19] Ni, G., Zhang, H., Liu, H.C., Yang, S.P., Geng, M.Y., Yue, J.M., Cytotoxic sesquiterpenoids from Sarcandra glabra. Tetrahedron 69 (2013), 564–569.
20. [20] Kim, S.Y., Kashiwada, Y., Kawazoe, K., Murakami, K., Sun, H.D., Li, S.L., Takaishi, Y., Spicachlorantins G-J, new lindenane sesquiterpenoid dimers from the roots of Chloranthus spicatus. Chem. Pharm. Bull. 59 (2011), 1281–1284.
21. [21] Xu, Y.J., Tang, C.P., Ke, C.Q., Zhang, J.B., Weiss, H.C., Gesing, E.R., Ye, Y., Mono- and di-sesquiterpenoids from Chloranthus spicatus. J. Nat. Prod. 70 (2007), 1987–1990.
22. [22] Kawabata, J., Fukushi, E., Mizutani, J., Sesquiterpene dimers from Chloranthus japonicus. Phytochemistry 39 (1995), 121–125.
23. [23] Yang, S.P., Yue, J.M., Chloramultilide A, a highly complex sesquiterpenoid dimmer from Chloranthus multistachys. Tetrahedron Lett. 47 (2006), 1129–1132.
24. [24] Wakita, T., Isolation of JFH-1 strain and development of an HCV infection system. Methods Mol. Biol. 510 (2009), 305–327.